LENZ Therapeutics’ Eye Drop Scores First FDA Approval For Age-Related Blurred Vision Condition Impacting 128 Million People

All NewsAugust 1, 2025

LENZ Therapeutics’ VIZZ earns FDA approval as the first aceclidine-based eye drop to treat presbyopia, with U.S. launch expected in Q4 2025.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent